Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians

被引:14
作者
Albitar, Lina [1 ]
Abou Alchamat, Ghalia [2 ]
机构
[1] Arab Int Univ, Fac Pharm, Dept Pharmaceut, Damascus, Syria
[2] Damascus Univ, Fac Sci, Dept Biol, Damascus, Syria
关键词
Pharmacogenetics; Pharmacogenetic testing; Drug response; Genetic variations; Knowledge assessment; HEALTH-CARE PROFESSIONALS; CLINICAL IMPLEMENTATION; PERSONALIZED MEDICINE; HOSPITAL PHARMACISTS; COLORECTAL-CANCER; PERCEPTION; AWARENESS; ATTITUDE; SAFETY; US;
D O I
10.1186/s12913-021-07040-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Pharmacogenetics targets genetic variations that influence drug response. It is relatively a new science that has not been vastly employed in most developing countries including Syria. Therefore we aimed at evaluating the depth of knowledge in pharmacogenetics and the attitude towards it amongst Syrian pharmacists and physicians. Methods We carried out an internet-based questionnaire consisted of 26 questions, sent through specialized websites and private groups with a large number of pharmacists and physicians members. The survey was available online for a period of 1 month. Results The total number of respondents was 154, mostly female pharmacists. Our statistical analysis showed a strong positive association between profession (in favour of pharmacists) and pharmacogenetics knowledge p = 0.049; however, no correlation with experience p = 0.811 was found. A significant difference was reported between the knowledge of pharmacists and physicians p = 0.001 concerning drugs that need pharmacogenetics testing before being prescribed. The majority of respondents had no information about applying genetic tests in Syria before prescribing medications nor did they possess the knowledge regarding drugs that show differential responses in patients according to their unique genotypes. In our study, the percentage knowledge assessment score was low in general (mean +/- Standard deviation, SD) (46% +/- 13.9%). The majority of the respondents agreed that pharmacists should provide counselling to patients on the subject of pharmacogenetics. Respondents' opinions varied concerning making pharmacogenetics learning a priority. Conclusion Lack of pharmacogenetics knowledge was found amongst respondents in general. Our findings raise concerns about the lack of awareness amongst physicians, which may hinder the implementation of this crucial field in Syria. We suggest an emphasis on the role of education, training, and conducting genotyping research on the Syrian population.
引用
收藏
页数:8
相关论文
共 41 条
[1]   Ethiopian health care professionals' knowledge, attitude, and interests toward pharmacogenomics [J].
Abdela, Ousman Abubeker ;
Bhagavathula, Akshaya Srikanth ;
Gebreyohannes, Eyob Alemayehu ;
Tegegn, Henok Getachew .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 :279-285
[2]   Individualized medicine enabled by genomics in Saudi Arabia [J].
Abu-Elmagd, Muhammad ;
Assidi, Mourad ;
Schulten, Hans-Juergen ;
Dallol, Ashraf ;
Pushparaj, Peter Natesan ;
Ahmed, Farid ;
Scherer, Stephen W. ;
Al-Qahtani, Mohammed .
BMC MEDICAL GENOMICS, 2015, 8
[3]   Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait [J].
Albassam, Abdullah ;
Alshammari, Shahad ;
Ouda, Ghadeer ;
Koshy, Samuel ;
Awad, Abdelmoneim .
PLOS ONE, 2018, 13 (09)
[4]   An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists [J].
AlEjielat, Rowan ;
Ejielat, Zeyad ;
Andrawes, Shireen ;
Mhaidat, Nizar M. .
PERSONALIZED MEDICINE, 2016, 13 (02) :143-154
[5]   Knowledge, Perception, and Application of Pharmacogenomics Among Hospital Pharmacists in Saudi Arabia [J].
Algahtani, Mohammed .
RISK MANAGEMENT AND HEALTHCARE POLICY, 2020, 13 :1279-1291
[6]   Knowledge, perception, and confidence of hospital pharmacists toward pharmacogenetics in Jeddah, Kingdom of Saudi Arabia [J].
Bagher, Amina M. ;
Neamatallah, Thikryat ;
Balto, Ghadeer ;
Almikhy, Lina ;
Almutairi, Sara S. ;
Abushal, Mohammed O. ;
Baghlaf, Khlood ;
Bagher, Sara M. .
SAUDI PHARMACEUTICAL JOURNAL, 2021, 29 (01) :53-58
[7]   A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations [J].
Bank, Paul C. D. ;
Swen, Jesse J. ;
Guchelaar, Henk-Jan .
PHARMACOGENOMICS, 2017, 18 (03) :215-225
[8]  
Bannur Z, 2014, INT MED J MALAYS, V13, P41
[9]   5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine [J].
Botticelli, Andrea ;
Scagnoli, Simone ;
Roberto, Michela ;
Lionetto, Luana ;
Cerbelli, Bruna ;
Simmaco, Maurizio ;
Marchetti, Paolo .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (08) :1836-1842
[10]  
Bruera G, 2020, PHARMACOGEN PERS MED, V13, P601, DOI [10.2147/PGPm.S253586, 10.2147/PGPM.S253586]